Pharma IP Circle

A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions

Tuesday, November 24, 2020

Epinephrine – USA

›
On Nov. 23, 2020, Federal Circuit affirmed district court & held that Hospira’s ANDA infringes composition limitations. Background of ...
Friday, November 6, 2020

Efinaconazole - USA

›
On Nov. 05, 2020 Federal Circuit affirmed-in-part district court’s interpretation of proper venue in Hatch-Waxman cases. Mylan (Mylan Phar...
Wednesday, November 4, 2020

Dapagliflozin – India

›
Brief background of the case is like this. Plaintiff, Astrazeneca filed suit against number of generic companies for launching generic dapag...
Saturday, October 24, 2020

Weekly Patent Litigation Round-Up

›
  SPCs and orphan drugs-- is the double layer getting messy or is it just a matter of timing? A new ruling of the District Court in the Hagu...
Wednesday, October 21, 2020

Pirfenidone - USA

›
Claim Construction (District of Delaware): Oct. 20, 2020 Civil Action No .: 19-cv-78 -RGA Plaintiff : Genentech, Inc. et al. Defendan...
2 comments:
Tuesday, October 6, 2020

Everolimus - USA

›
  IPR decision: Oct. 05, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...
Saturday, October 3, 2020

Carvedilol – USA

›
  On Oct 02, 2020, Federal Circuit vacated district court’s grant of JMOL and reinstated the jury verdicts of infringement and damages. Ba...
Friday, October 2, 2020

Ceritinib – India

›
On Sep 29, 2020, Intellectual Property Appellate Board (IPAB) set aside the order of Learned Controller finding compound patent invalid. B...

Ibrutinib - India

›
  On Sep 29, 2020, Intellectual Property Appellate Board (IPAB) set aside the order of Learned Controller finding compound patent invalid. ...
Wednesday, September 30, 2020

Ezetimibe & Simvastatin – France

›
  On Sep 25, 2020, Court of appeal of Paris found SPC for combination of ezetimibe & simvastatin product invalid. Background : Merck...
‹
›
Home
View web version

Mahendraa

Mahendraa
View my complete profile
Powered by Blogger.